Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells

被引:34
作者
Kallio, Anu [2 ,3 ]
Guo, Tao [2 ,4 ,5 ]
Lamminen, Elisa [2 ]
Seppanen, Jani [2 ]
Kangas, Lauri [6 ]
Vaananen, H. Kalervo [2 ]
Harkonen, Pirkko [1 ]
机构
[1] Lund Univ, MAS Univ Hosp, Dept Lab Med, S-20502 Malmo, Sweden
[2] Univ Turku, Inst Biomed, Dept Anat, FIN-20520 Turku, Finland
[3] Turku Grad Sch Biomed Sci, Turku, Finland
[4] Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Wuhan 430022, Hubei, Peoples R China
[5] Lab Biotargeted Therapy Hubei Prov, Wuhan 430022, Hubei, Peoples R China
[6] Hormos Med Ltd, Turku, Finland
基金
芬兰科学院;
关键词
osteoblast; U2OS; estradiol; estrogen receptor; OPG; IL-6;
D O I
10.1016/j.mce.2008.03.005
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In the current work, we compared the ability of 17 beta-estradiol (E-2) and the selective estrogen receptor modulators (SERMs), tamoxifen (Tam), raloxifene (Ral) and ospemifene (Osp) to promote the survival of osteoblast-derived cells against etoposide-incluced apoptosis. In order to compare the roles of the two estrogen receptor (ER) isotypes, we created a U2OS human osteosarcoma cell line stably expressing either ERalpha (ER alpha) or ERbeta (ER beta). Transfection with either of the ERs was able to render the U2OS cells sensitive to E-2. We show that E2 opposed etoposide-induced apoptosis and that the effect was mediated via both ER isotypes. The ER isotype selective agonists propyl-pyrazole-triol (PPT) and diarylpropionitrile (DPN) had the same effect in U2OS/ER alpha and U20S/ER beta cells, respectively. Osp also opposed apoptosis at least in U2OS/ERa cells. Tam and Ral were not able to protect against etoposide-induced cell death. In order to evaluate the protective effects of E-2 and Osp upon etoposide challenge, we studied the expression of two E-2-regulated, osteoblast-produced cytokines, IL-6 and OPG in E-2 and SERM-treated U2OS/ER alpha and U2OS/ER beta cells. Etoposide strongly increased expression of IL-6 and decreased that of OPG. E-2 opposed IL-6 increase only in U2OS/ER alpha cells and OPG decrease primarily in ER beta cells. Osp opposed the effect of etoposide on OPG primarily in U2OS/ER beta cells but interestingly, it had little effect on IL-6 expression. E2, PPT, DNP and Osp also inhibited etoposide-induced death and cytokine changes in SAOS-2 osteosarcoma cells expressing endogenous ER alpha and ER beta. Collectively, our results suggest that the osteoblast protective anti-apoptotic effects of E-2 are mediated by both ER alpha and ER beta but those of Osp primarily by ER alpha. In addition, E-2 and Osp opposed the etoposide-induced increase of IL-6 and decrease of OPG which changes would increase osteoclastic activity. These anti-resorptive effects of E-2 and Osp upon etoposide challenge differed from each other and they seemed to be differentially mediated in ER(x and ER beta expressing osteoblast-derived U2OS cells. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:38 / 48
页数:11
相关论文
共 80 条
[1]   Changes in RANKL/OPG/RANK gene expression in peripheral mononuclear cells following treatment with estrogen or raloxifene [J].
Bashir, A ;
Mak, Y ;
Sankaralingam, S ;
Cheung, J ;
Mc Gowan, NWA ;
Grigoriadis, AE ;
Fogelman, I ;
Hampson, G .
STEROIDS, 2005, 70 (13) :847-855
[2]   The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts [J].
Bord, S ;
Ireland, DC ;
Beavan, SR ;
Compston, JE .
BONE, 2003, 32 (02) :136-141
[3]   Differential response of estrogen receptors α and β to SP500263, a novel potent selective estrogen receptor modulator [J].
Brady, H ;
Doubleday, M ;
Gayo-Fung, LM ;
Hickman, M ;
Khammungkhune, S ;
Kois, A ;
Lipps, S ;
Pierce, S ;
Richard, N ;
Shevlin, G ;
Sutherland, MK ;
Anderson, DW ;
Bhagwat, SS ;
Stein, B .
MOLECULAR PHARMACOLOGY, 2002, 61 (03) :562-568
[4]   Dehydroepiandrosterone stimulates the estrogen response element [J].
Bruder, JM ;
Sobek, L ;
Oettel, M .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1997, 62 (5-6) :461-466
[5]   Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells [J].
Bynoe, MS ;
Grimaldi, CM ;
Diamond, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2703-2708
[6]   Estradiol protects against ethanol-induced bone loss by inhibiting up-regulation of receptor activator of nuclear factor-κB ligand in osteoblasts [J].
Chen, Jin-Ran ;
Haley, Rani Lynn ;
Hidestrand, Mats ;
Shankar, Kartik ;
Liu, Xiaoli ;
Lumpkin, Charles K. ;
Simpson, Pippa M. ;
Badger, Thomas M. ;
Ronis, Martin J. J. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (03) :1182-1190
[7]   Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor κB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells:: comparison of the effects of 17-β oestradiol and raloxifene [J].
Cheung, J ;
Mak, YT ;
Papaioannou, S ;
Evans, BAJ ;
Fogelman, I ;
Hampson, G .
JOURNAL OF ENDOCRINOLOGY, 2003, 177 (03) :423-433
[8]   Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells [J].
Choi, KC ;
Kang, SK ;
Tai, CJ ;
Auersperg, N ;
Leung, PCK .
ENDOCRINOLOGY, 2001, 142 (06) :2351-2360
[9]   Breast cancer bone metastasis and current small therapeutics [J].
Cicek, Muzaffer ;
Oursler, Merry Jo .
CANCER AND METASTASIS REVIEWS, 2006, 25 (04) :635-644
[10]   Sex steroids and bone [J].
Compston, JE .
PHYSIOLOGICAL REVIEWS, 2001, 81 (01) :419-447